Surfactant function and composition in premature infants treated with inhaled nitric oxide

Pediatrics

Volumn 120, Issue 2, 2007, Pages 346-353

  Ballard, Philip L ^a,e   Merrill, Jeffrey D ^b   Truog, William E ^b   Godinez, Rodolfo I ^b   Godinez, Marye H ^b   McDevitt, Theresa M ^b   Ning, Yue ^b   Golombek, Sergio G ^c   Parton, Lance A ^c   Luan, Xianqun ^d   Cnaan, Avital ^d   Ballard, Roberta A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Nitric oxide; Premature infant; Respiratory severity score; Surface tension; Surfactant dysfunction

Indexed keywords

LUNG SURFACTANT; NITRIC OXIDE; PHOSPHOLIPID; PLACEBO; PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREMATURITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SURFACE TENSION; TRACHEA;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NITRIC OXIDE; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; SURFACE TENSION;

EID: 34547657934     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0095     Document Type: Article

References (37)

1. Jobe AH, Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annu Rev Physiol. 2000;62:825-846
2. Merrill JD, Ballard RA, Cnaan A, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res. 2004;56:1-9
3. Gunther A, Schmidt R, Harodt J, et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant proteins. Eur Respir J. 2002;19:797-804
4. Ballard PL. Hormonal regulation of pulmonary surfactant. Endocr Rev. 1989;10:165-181
5. Matalon S, DeMarco V, Haddad IY, et al. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol. 1996;270:L273-L280
6. Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe T, Matalon S. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J Physiol. 1996;270:L898-L906
7. Ayad O, Wong HR. Nitric oxide decreases surfactant protein A gene expression in H441 cells. Crit Care Med. 1998;26:1277-1282
8. Bhandari V, Johnson L, Smith-Kirwin S, Vigliotta G, Funanage V, Chander A. Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type II pneumocytes. Lung. 2002;180:301-317
9. Salinas D, Sparkman L, Berhane K, Boggaram V. Nitric oxide inhibits surfactant protein B gene expression in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1153-L1165
10. Sparkman L, Boggaram V. Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L764-L773
11. Lee JW, Gonzalez RF, Chapin CJ, Busch J, Fineman JR, Gutierrez JA. Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2005;288:L950-L957
12. Hallman M, Waffarn F, Bry K, et al. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol. 1996;80:2026-2034
13. Stuart RB, Ovadia B, Suzara VV, et al. Inhaled nitric oxide increases surfactant protein gene expression in the intact lamb. Am J Physiol Lung Cell Mol Physiol. 2003;285:L628-L633
14. Valino F, Casals C, Guerrero R, et al. Inhaled nitric oxide affects endogenous surfactant in experimental lung transplantation. Transplantation. 2004;77:812-818
15. Ballard PL, Gonzales LW, Godinez RI, et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res. 2006;59:157-162
16. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349:2099-2107
17. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for preterm infants with severe respiratory failure. N Engl J Med. 2005;353:13-22
18. Field D, Elbourne D, Truesdale A, et al. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339). Pediatrics. 2005;115:926-936
19. Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355:343-353
20. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355:354-364
21. Katz LA, Klein JM. Repeat surfactant therapy for postsurfactant slump. J Perinatol. 2006;26:414-422
22. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol. 1977;43:198-203
23. Ballard PL, Merrill JD, Godinez RI, Godinez MH, Truog WE, Ballard RA. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med. 2003;168:1123-1128
24. Ballard PL, Ning Y, Polk D, Ikegami M, Jobe AH. Glucocorticoid regulation of surfactant components in immature lambs. Am J Physiol. 1997;273:L1048-L1057
25. Wali A, Beers MF, Dodia C, Feinstein SI, Fisher AB. ATP and adenosine 3′,5′-cyclic monophosphate stimulate the synthesis of surfactant protein A in rat lung. Am J Physiol. 1993;264:L431-L437
26. Beers MF, Shuman H, Liley HG, et al. Surfactant protein B in human fetal lung: developmental and glucocorticoid regulation. Pediatr Res. 1995;38:668-675
27. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Med Sci. 1959;37:911-917
28. Dittmer JC, Wells MA. Quantitative and qualitative analysis of lipids and lipid components. In: Methods in Enzymology. Lowenstein JM, ed. New York, NY: Academic Press; 1969:482-487
29. Blackwelder WC. Equivalence Trials. New York, NY: Wiley; 1998
30. Truog WE, Ballard PL, Norberg M, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics. 2007;119:670-678
31. Bernhard W, Haagsman HP, Tschernig T, et al. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Am J Respir Cell Mol Biol. 1997;17:41-50
32. Dargaville PA, South M, McDougall PN. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med. 1999;160:771-777
33. D'Angio CT, Basavegowda K, Avissar NE, Finkelstein JN, Sinkin RA. Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants. Biol Neonate. 2002;82:145-149
34. Pandit PB, Dunn MS, Kelly EN, Perlman M. Surfactant replacement in neonates with early chronic lung disease. Pediatrics. 1995;95:851-854
35. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med. 2005;172:899-906
36. McCurnin DC, Pierce RA, Chang LY, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2005;288:L450-L459
37. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol. 2006;291:L119-L127